ArticleNature reviews. Drug discovery2023
Artificial intelligence in European medicines regulation.
Article in Nature reviews. Drug discovery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Better data for better medicines: a path to data-driven medicines regulation.Nature reviews. Drug discovery · 2026Article
- Artificial Intelligence for Regulatory Evidence: A Systematic Document Analysis of European Medicines Agency Regulatory Advice and Public Reports.Clinical pharmacology and therapeutics · 2026Article
- The history of state preemption and medical device regulation: lessons for artificial intelligence oversight.Health affairs scholar · 2026Article
- Development and application of artificial intelligence in traditional Chinese medicine research and development.Chinese medicine · 2026Review
- Beyond Post hoc Explanations: A Comprehensive Framework for Accountable AI in Medical Imaging Through Transparency, Interpretability, and Explainability.Bioengineering (Basel, Switzerland) · 2025Review
- Explanation and elaboration of MedinAI: guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services.International journal of clinical pharmacy · 2025Article
- Current landscape of innovative drug development and regulatory support in China.Signal transduction and targeted therapy · 2025Review
- Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal Health.Clinical pharmacology and therapeutics · 2025Article
- The applications and advances of artificial intelligence in drug regulation: A global perspective.Acta pharmaceutica Sinica. B · 2025Review
- The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System.Drug safety · 2024Review
- Trustworthy Artificial Intelligence in Dentistry: Learnings from the EU AI Act.Journal of dental research · 2024Review
- Safety regulation of machine learning in cardiac surgery.Journal of thoracic disease · 2024Article
- Sync fast and solve things-best practices for responsible digital health.NPJ digital medicine · 2024Article
- Governance of artificial intelligence and machine learning in pharmacovigilance: what works today and what more is needed?Therapeutic advances in drug safety · 2024Article
- Trustworthy AI for safe medicines.Nature reviews. Drug discovery · 2023Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
36411368What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.